Zhang Lei portfolio, Q4 2025

HHLR Advisors (Hillhouse) · 13F for the quarter ending Dec 31, 2025

For Q4 2025, HHLR Advisors (Hillhouse) reported $3.1B across 33 US-listed positions, led by PDD (39.2%), BABA (25.6%) and ONC (10.1%). Compared with its filing for Q3 2025, Zhang Lei opened 6 new positions, added to 2, reduced 3 and sold out of 6; 22 positions did not change.

The largest purchase was an addition to BABA ($313.8M); the largest sale, a reduction of FUTU ($264M).

Reported value
$3.1B
Positions
33
In the top 10
96%
Filed
Feb 17
2026

Key facts

13F portfolio value
$3.1BQ4 2025
Positions
33
Largest holding
PDD 39.2%
New positions
6
Sold out
6
Filed
Feb 17, 2026

Holdings as of (Q4 2025), filed with the SEC on . Changes are measured against the filing for Sep 30, 2025. Every tracked investor's Q4 2025 13F.

Bought and sold in Q4 2025

Zhang Lei: buys and sells in Q4 2025
StockMoveSharesSizeOf portfolio
Alibaba Group Holding LtdBABA▲ Added 65%+2.14M$313.8M10.1%
Futu Holdings LtdFUTU▼ Reduced 50%−1.61M$264M8.51%
PDD Holdings IncPDD▲ Added 25%+2.13M$241.4M7.78%
Baidu IncBIDU▼ Sold out−1.64M$216.2M6.97%
Webull CorpBULL▼ Reduced 82%−27.11M$210.6M6.79%
NetEase IncNTES▼ Sold out−790.81K$120.2M3.87%
Full Truck Alliance CoYMM▼ Sold out−4.07M$52.7M1.70%
Sea LtdSE▼ Sold out−180.05K$32.2M1.04%
Arrivent Biopharma IncAVBP▼ Reduced 12%−555.56K$11.2M0.36%
Smart SH Global Ltdno ticker on file
▼ Sold out−3.95M$5.3M0.17%
Taiwan Semiconductor Manufacturing Company LtdTSM▲ New+11.3K$3.4M0.11%
Alphabet IncGOOGL▲ New+7.3K$2.3M0.07%
Bright Scholar ED Holdings Ltdno ticker on file
▼ Sold out−988.14K$1.9M0.06%
iShares Bitcoin Trust ETFIBIT▲ New+35.3K$1.8M0.06%
Centrais Elet Bras SAno ticker on file
▲ New+96.6K$884.9K0.03%
Vnet Group IncVNET▲ New+53.1K$449.2K0.01%
Centrais Elet Bras SAno ticker on file
▲ New+25.39K$218.9K0.01%

Holdings at the quarter's end

Zhang Lei holdings, Q4 2025
#StockSectorShare of portfolioValueSharesReported priceHeldSince Q3 2025
1PDD Holdings IncPDD · SPONSORED ADSConsumer Discretionary39.2%$1.2B10.72M$113.397+ qtrs▲ Added 25%
2Alibaba Group Holding LtdBABA · SPONSORED ADSConsumer Discretionary25.6%$796M5.43M$146.587+ qtrs▲ Added 65%
3Beone Medicines LtdONC · SPONSORED ADSHealth Care10.1%$314.2M1.03M$303.817+ qtrsNo change
4Futu Holdings LtdFUTU · SPON ADS CL AFinancials8.63%$267.7M1.63M$164.217+ qtrs▼ Reduced 50%
5Legend Biotech CorpLEGN · SPONSORED ADSHealth Care4.19%$130.1M5.98M$21.747+ qtrsNo change
6Arrivent Biopharma IncAVBP—2.55%$79.1M3.93M$20.127+ qtrs▼ Reduced 12%
7KE Holdings IncBEKE · SPONSORED ADSReal Estate2.15%$66.8M4.24M$15.767+ qtrsNo change
8Webull CorpBULL · ORD SHS—1.50%$46.4M5.97M$7.773 qtrs▼ Reduced 82%
9Cytek Biosciences IncCTKB—1.08%$33.6M6.66M$5.057+ qtrsNo change
10
Clearwater Analytics Holdingsno ticker on file · CL A
—1.06%$32.9M1.37M$24.123 qtrsNo change
11Novabridge BiosciencesNBP · SPONSORED ADS—0.77%$23.8M5.98M$3.987+ qtrsNo change
12Yatsen Holding LtdYSG · SPONSORED ADS—0.61%$19M4.89M$3.897+ qtrsNo change
13Maze Therapeutics IncMAZE—0.61%$19M457.54K$41.434 qtrsNo change
14Gossamer Bio IncGOSS—0.50%$15.4M4.97M$3.107+ qtrsNo change
15Agora IncAPI · ADS—0.28%$8.5M2.1M$4.075 qtrsNo change
16Contineum Therapeutics IncCTNM · CL A—0.25%$7.7M669.34K$11.437+ qtrsNo change
17Sagimet Biosciences IncSGMT—0.14%$4.3M724.8K$5.927+ qtrsNo change
18Taiwan Semiconductor Manufacturing Company LtdTSM · SPONSORED ADSTechnology0.11%$3.4M11.3K$303.891 qtrNew
19Tuya IncTUYA · SPONSERED ADS—0.11%$3.3M1.56M$2.117+ qtrsNo change
20GE AerospaceGEIndustrials0.10%$3.1M10.04K$308.037+ qtrsNo change
21Alphabet IncGOOGL · CAP STK CL ACommunication0.07%$2.3M7.3K$313.001 qtrNew
22Mogu IncMOGU · SPON ADS—0.06%$1.8M847.51K$2.137+ qtrsNo change
23iShares Bitcoin Trust ETFIBIT · SHS BEN INT—0.06%$1.8M35.3K$49.651 qtrNew
24Pacific Biosciences of California IncPACB—0.06%$1.7M918.89K$1.877+ qtrsNo change
25Moodys CorpMCOFinancials0.05%$1.5M2.89K$510.857+ qtrsNo change
26Equinox Gold CorpEQXMaterials0.04%$1.1M80.5K$14.042 qtrsNo change
27Barrick Mining CorpBMaterials0.04%$1.1M25.4K$43.552 qtrsNo change
28
Centrais Elet Bras SAno ticker on file · SPONSORED ADR
—0.03%$884.9K96.6K$9.161 qtrNew
29Aligos Therapeutics IncALGS—0.02%$710.6K76.25K$9.327+ qtrsNo change
30Vnet Group IncVNET · SPONSORED ADS A—0.01%$449.2K53.1K$8.461 qtrNew
31
Centrais Elet Bras SAno ticker on file · SPON ADS PF CL C
—0.01%$218.9K25.39K$8.621 qtrNew
32Uxin LtdUXIN · SPONSORED ADS—0.00%$64.6K19.16K$3.377+ qtrsNo change
33Ridgetech IncRDGT · SHS NEW—0.00%$57.5K20.17K$2.857+ qtrsNo change

By sector

Zhang Lei portfolio by sector, Q4 2025
SectorShare of portfolioValuePositions
Consumer Discretionary64.8%$2B2
Health Care14.3%$444.3M2
Financials8.67%$269.2M2
Real Estate2.15%$66.8M1
Technology0.11%$3.4M1
Industrials0.10%$3.1M1
Communication0.07%$2.3M1
Materials0.07%$2.2M2
No sector on file9.69%$300.7M21

Questions and answers

What did Zhang Lei own in Q4 2025?

HHLR Advisors (Hillhouse)'s 13F for Q4 2025 lists 33 positions worth $3.1B. The largest: PDD (39.2%), BABA (25.6%), ONC (10.1%), FUTU (8.6%), LEGN (4.2%).

What did Zhang Lei buy in Q4 2025?

The largest purchases, by the shares bought at the quarter-end price the filing implies: BABA (added, $313.8M), PDD (added, $241.4M), TSM (new, $3.4M), GOOGL (new, $2.3M), IBIT (new, $1.8M), Centrais Elet Bras SA (new, $884.9K).

What did Zhang Lei sell in Q4 2025?

The largest sales: FUTU (reduced, $264M), BIDU (sold out, $216.2M), BULL (reduced, $210.6M), NTES (sold out, $120.2M), YMM (sold out, $52.7M), SE (sold out, $32.2M).

When was this filing made?

HHLR Advisors (Hillhouse) filed its 13F for the quarter ending Dec 31, 2025 on Feb 17, 2026. A 13F is due within 45 days of the quarter's end, so the positions were already weeks old when it became public.

Learn

Cite this page

Funkfolio, “Zhang Lei portfolio, Q4 2025: HHLR Advisors (Hillhouse) 13F holdings”, data as of 17 February 2026. https://funkfolio.com/gurus/hillhouse/2025-q4

Underlying data: SEC EDGAR, Form 13F-HR of HHLR Advisors (Hillhouse) (CIK 1762304) for the period ending Dec 31, 2025.

Source: SEC EDGAR, Form 13F-HR for HHLR Advisors (Hillhouse) (CIK 1762304), period ending Dec 31, 2025, filed Feb 17, 2026. Changes compare share counts with the filing for Sep 30, 2025; a share split in between is allowed for where one is on record. “Reported price” is a position's reported value divided by its shares. The size of a buy or sell is the change in shares at that price; a position sold out is sized at its value in the previous filing, and “of portfolio” sets the size against the $3.1B reported for this quarter. “Held” counts consecutive quarterly filings up to this one, out of the 7 looked at from here back. Sectors are those of the ranked companies on this site as they stand today. Not a live portfolio and not advice.